Download 2015 CPT Changes Pathology and Laboratory Services

2015 CPT Changes
Pathology and Laboratory Services
Each year, the American Medical Association publishes the Current Procedural Terminology (CPT®)
manual which lists all the available CPT billing codes for the next year, including all the code changes.
Here are the pathology and laboratory CPT code changes for 2015. There are over 100 new codes, 47
deleted codes and 31 revised codes for pathology.
CPT® is a registered trademark of the American Medical Association.
New Pathology & Laboratory CPT Codes
80163 Digoxin; free
80165 Valproic acid (dipropylacetic acid); free
80300 Drug screen, any number of drug classes from Drug Class List A; any number of non-TLC devices
or procedures, (eg, immunoassay) capable of being read by direct optical observation, including
instrumented-assisted when performed (eg, dipsticks, cups, cards, cartridges), per date of service
80301 Drug screen, any number of drug classes from Drug Class List A; single drug class method, by
instrumented test systems (eg, discrete multichannel chemistry analyzers utilizing immunoassay or
enzyme assay), per date of service
80302 Drug screen, presumptive, single drug class from Drug Class List B, by immunoassay (eg, ELISA) or
non-TLC chromatography without mass spectrometry (eg, GC, HPLC), each procedure
80303 Drug screen, any number of drug classes, presumptive, single or multiple drug class method; thin
layer chromatography procedure(s) (TLC) (eg, acid, neutral, alkaloid plate), per date of service
80304 Drug screen, any number of drug classes, presumptive, single or multiple drug class method; not
otherwise specified presumptive procedure (eg, TOF, MALDI, LDTD, DESI, DART), each procedure
80320 Alcohols
80321 Alcohol biomarkers; 1 or 2
80322 Alcohol biomarkers; 3 or more
80323 Alkaloids, not otherwise specified
80324 Amphetamines; 1 or 2
80325 Amphetamines; 3 or 4
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
80326 Amphetamines; 5 or more
80327 Anabolic steroids; 1 or 2
80328 Anabolic steroids; 3 or more
80329 Analgesics, non-opioid; 1 or 2
80330 Analgesics, non-opiod; 3-5
80331 Analgesics, non-opioid; 6 or more
80332 Antidepressants, serotonergic class; 1 or 2
80333 Antidepressants, serotonergic class; 3-5
80334 Antidepressants, serotonergic class; 6 or more
80335 Antidepressants, tricyclic and other cyclicals; 1 or 2
80336 Antidepressants, tricyclic and other cyclicals; 3-5
80337 Antidepressants, tricyclic and other cyclicals; 6 or more
80338 Antidepressants, not otherwise specified
80339 Antiepileptics, not otherwise specified; 1-3
80340 Antiepileptics, not otherwise specified; 4-6
80341 Antiepileptics, not otherwise specified; 7 or more
80342 Antipsychotics, not otherwise specified; 1-3
80343 Antipsychotics, not otherwise specified; 4-6
80344 Antipsychotics, not otherwise specified; 7 or more
80345 Barbiturates
80346 Benzodiazepines; 1-12
80347 Benzodiazepines; 13 or more
80348 Buprenorphine
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
80349 Cannabinoids, natural
80350 Cannabinoids, synthetic; 1-3
80351 Cannabinoids, synthetic; 4-6
80352 Cannabinoids, synthetic; 7 or more
80353 Cocaine
80354 Fentanyl
80355 Gabapentin, non-blood
80356 Heroin metabolite
80357 Ketamine and norketamine
80358 Methadone
80359 Methylenedioxyamphetamines (MDA, MDEA, MDMA)
80360 Methylphenidate
80361 Opiates, 1 or more
80362 Opioids and opiate analogs; 1 or 2
80363 Opioids and Opiate analogs; 3 or 4
80364 Opioids and Opiate analogs; 5 or more
80365 Oxycodone
80366 Pregabalin
80367 Propoxyphene
80368 Sedative hypnotics (non-benzodiazepines)
80369 Skeletal muscle relaxants; 1 or 2
80370 Skeletal muscle relaxants; 3 or more
80371 Stimulants, synthetic
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
80372 Tapentadol
80373 Tramadol
80374 Stereoisomer (enantiomer) analysis, single drug class
80375 Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 1-3
80376 Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 4-6
80377 Drug(s) or substance(s), definitive, qualitative or quantitative, not otherwise specified; 7 or more
81246 FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis; tyrosine kinase
domain (TKD) variants (eg, D835, I836)
81288 MLH1 (mutL homolog 1, colon cancer, nonpolyposis type 2) (eg, hereditary non-polyposis
colorectal cancer, Lynch syndrome) gene analysis; promoter methylation analysis
81313 PCA3/KLK3 (prostate cancer antigen 3 [non-protein coding]/kallikrein-related peptidase 3
[prostate specific antigen]) ratio (eg, prostate cancer)
81410 Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos
syndrome type IV, arterial tortuosity syndrome); genomic sequence analysis panel, must include
sequencing of at least 9 genes, including FBN1, TGFBR1, TGFBR2, COL3A1, MYH11, ACTA2, SLC2A10,
SMAD3, and MYLK
81411 Aortic dysfunction or dilation (eg, Marfan syndrome, Loeys Dietz syndrome, Ehler Danlos
syndrome type IV, arterial tortuosity syndrome); duplication/deletion analysis panel, must include
analyses for TGFBR1, TGFBR2, MYH11, and COL3A1
81415 Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis
81416 Exome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis,
each comparator exome (eg, parents, siblings) (List separately in addition to code for primary
procedure)
81417 Exome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of
previously obtained exome sequence (eg, updated knowledge or unrelated condition/syndrome)
81420 Fetal chromosomal aneuploidy (eg, trisomy 21, monosomy X) genomic sequence analysis panel,
circulating cell-free fetal DNA in maternal blood, must include analysis of chromosomes 13, 18, and 21
81425 Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
81426 Genome (eg, unexplained constitutional or heritable disorder or syndrome); sequence analysis,
each comparator genome (eg, parents, siblings) (List separately in addition to code for primary
procedure)
81427 Genome (eg, unexplained constitutional or heritable disorder or syndrome); re-evaluation of
previously obtained genome sequence (eg, updated knowledge or unrelated condition/syndrome)
81430 Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome); genomic
sequence analysis panel, must include sequencing of at least 60 genes, including CDH23, CLRN1, GJB2,
GPR98, MTRNR1, MYO7A, MYO15A, PCDH15, OTOF, SLC26A4, TMC1, TMPRSS3, USH1C, USH1G, USH2A,
and WFS1
81231 Hearing loss (eg, nonsyndromic hearing loss, Usher syndrome, Pendred syndrome);
duplication/deletion analysis panel, must include copy number analyses for STRC and DFNB1 deletions
in GJB2 and GJB6 genes
81435 Hereditary colon cancer syndromes (eg, Lynch syndrome, familial adenomatosis polyposis);
genomic sequence analysis panel, must include analysis of at least 7 genes, including APC, CHEK2, MLH1,
MSH2, MSH6, MUTYH, and PMS2
81436 Hereditary colon cancer syndromes (eg, Lynch syndrome, familial adenomatosis polyposis);
duplication/deletion gene analysis panel, must include analysis of at least 8 genes, including APC, MLH1,
MSH2, MSH6, PMS2, EPCAM, CHEK2, and MUTYH
81440 Nuclear encoded mitochondrial genes (eg, neurologic or myopathic phenotypes), genomic
sequence panel, must include analysis of at least 100 genes, including BCS1L, C10orf2, COQ2, COX10,
DGUOK, MPV17, OPA1, PDSS2, POLG, POLG2, RRM2B, SCO1, SCO2, SLC25A4, SUCLA2, SUCLG1, TAZ, TK2,
and TYMP
81445 Targeted genomic sequence analysis panel, solid organ neoplasm, DNA analysis, 5-50 genes (eg,
ALK, BRAF, CDKN2A, EGFR, ERBB2, KIT, KRAS, NRAS, MET, PDGFRA, PDGFRB, PGR, PIK3CA, PTEN, RET),
interrogation for sequence variants and copy number variants or rearrangements, if performed
81450 Targeted genomic sequence analysis panel, hematolymphoid neoplasm or disorder, DNA and RNA
analysis when performed, 5-50 genes (eg, BRAF, CEBPA, DNMT3A, EZH2, FLT3, IDH1, IDH2, JAK2, KRAS,
KIT, MLL, NRAS, NPM1, NOTCH1), interrogation for sequence variants, and copy number variants or
rearrangements, or isoform expression or mRNA expression levels, if performed
81455 Targeted genomic sequence analysis panel, solid organ or hematolymphoid neoplasm, DNA and
RNA analysis when performed, 51 or greater genes (eg, ALK, BRAF, CDKN2A, CEBPA, DNMT3A, EGFR,
ERBB2, EZH2, FLT3, IDH1, IDH2, JAK2, KIT, KRAS, MLL, NPM1, NRAS, MET, NOTCH1, PDGFRA, PDGFRB,
PGR, PIK3CA, PTEN, RET), interrogation for sequence variants and copy number variants or
rearrangements, if performed
81460 Whole mitochondrial genome (eg, Leigh syndrome, mitochondrial encephalomyopathy, lactic
acidosis, and stroke-like episodes [MELAS], myoclonic epilepsy with ragged-red fibers [MERFF],
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
neuropathy, ataxia, and retinitis pigmentosa [NARP], Leber hereditary optic neuropathy [LHON]),
genomic sequence, must include sequence analysis of entire mitochondrial genome with heteroplasmy
detection
81465 Whole mitochondrial genome large deletion analysis panel (eg, Kearns-Sayre syndrome, chronic
progressive external ophthalmoplegia), including heteroplasmy detection, if performed
81470 X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID); genomic sequence
analysis panel, must include sequencing of at least 60 genes, including ARX, ATRX, CDKL5, FGD1, FMR1,
HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and SLC16A2
81471 X-linked intellectual disability (XLID) (eg, syndromic and non-syndromic XLID);
duplication/deletion gene analysis, must include analysis of at least 60 genes, including ARX, ATRX,
CDKL5, FGD1, FMR1, HUWE1, IL1RAPL, KDM5C, L1CAM, MECP2, MED12, MID1, OCRL, RPS6KA3, and
SLC16A2
81519 Oncology (breast), mRNA, gene expression profiling by real-time RT-PCR of 21 genes, utilizing
formalin-fixed paraffin embedded tissue, algorithm reported as recurrence score
87505 Growth stimulation expressed gene 2 (ST2, Interleukin 1 receptor like-1)
83006 Growth stimulation expressed gene 2 (ST2, Interleukin 1 receptor like-1)
87505 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg,
Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse
transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 35 targets
87506 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg,
Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse
transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 611 targets
87507 Infectious agent detection by nucleic acid (DNA or RNA); gastrointestinal pathogen (eg,
Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia), includes multiplex reverse
transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes,
12-25 targets
87623 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), low-risk
types (eg, 6, 11, 42, 43, 44)
87624 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk
types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68)
87625 Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16
and 18 only, includes type 45, if performed
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
87806 Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1
antigen(s), with HIV-1 and HIV-2 antibodies
88341 Immunohistochemistry or immunocytochemistry, per specimen; each additional single antibody
stain procedure (List separately in addition to code for primary procedure)
88344 Immunohistochemistry or immunocytochemistry, per specimen; each multiplex antibody stain
procedure
88364 In situ hybridization (eg, FISH), per specimen; each additional single probe stain procedure (List
separately in addition to code for primary procedure)
88366 In situ hybridization (eg, FISH), per specimen; each multiplex probe stain procedure
88369 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per
specimen; each additional single probe stain procedure (List separately in addition to code for primary
procedure)
88373 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computerassisted technology, per specimen; each additional single probe stain procedure (List separately in
addition to code for primary procedure)
88374 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), using computerassisted technology, per specimen; each multiplex probe stain procedure
88377 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative), manual, per
specimen; each multiplex probe stain procedure
89337 Cryopreservation, mature oocyte(s)
Deleted Pathology & Laboratory CPT Codes
80100 Drug screen, qualitative; multiple drug classes chromatographic method, each procedure
To report presumptive and/or definitive drug testing, see 80300, 80301, 80302, 80303, 80304
80101 Drug screen, qualitative; single drug class method (eg, immunoassay, enzyme assay), each drug
class
To report presumptive and/or definitive drug testing, see 80300, 80301, 80302, 80303, 80304
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
80102 Drug confirmation, each procedure
To report presumptive and/or definitive drug testing, see 80300, 80301, 80302, 80303, 80304
80103 Tissue preparation for drug analysis
To report presumptive and/or definitive drug testing, see 80300, 80301, 80302, 80303, 80304
80104 Drug screen, qualitative; multiple drug classes other than chromatographic method, each
procedure
To report presumptive and/or definitive drug testing, see 80300, 80301, 80302, 80303, 80304
80152 Amitriptyline
To report definitive drug testing for amitryptyline, see 80335, 80336, 80337
80154 Benzodiazepines
To report definitive drug testing for benzodiazepines, see 80346, 80347
80160 Desipramine
To report definitive drug testing for desipramine, see 80335, 80336, 80337
80166 Doxepin
To report definitive drug testing for doxepin, see 80335, 80336, 80337
80172 Gold
To report definitive drug testing for gold, use 80375
80174 Imipramine
To report testing for imipramine, see 80335, 80336, 80337
80182 Nortriptyline
To report definitive drug testing for nortriptyline, see 80335, 80336, 80337
80196 Salicylate
To report definitive drug testing for salicylate, see 80329, 80330, 80331
80440 Thyrotropin releasing hormone (TRH) stimulation panel; for hyperprolactinemia.
This panel must include the following: Prolactin (84146 x 3) For prolactin, use 84146
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
82000 Acetaldehyde, blood
.
82003 Acetaminophen
For acetaminophen, see 80329, 80330, 80331
82055 Alcohol (ethanol); any specimen except breath
For alcohol, any specimen except breath, see 80320, 80321, 80322
82101 Alkaloids, urine, quantitative
For alkaloids, use 80323
82145 Amphetamine or methamphetamine
For amphetamine or methamphetamine, see 80324, 80325, 80326
82205 Barbiturates, not elsewhere specified
For barbiturates not elsewhere specified, use 80345
82520 Cocaine or metabolite
For cocaine or metabolite, use 80353
82646 Dihydrocodeinone
For dihydrocodeinone,use 80361
82649 Dihydromorphinone For opiates, use 80361
82651 Dihydrotestosterone (DHT)
For anabolic steroids, see 80327, 80328
82654 Dimethadione
For dimethadione, see 80339, 80340, 80341 other codes.
82666 Epiandrosterone
For epiandrosterone, see 80327, 80328
82690 Ethchlorvynol
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
For ethchlorvynol, ethyl alcohol, use 80320
82742 Flurazepam
For flurazepam, see 80346, 80347
82953 Glucose; tolbutamide tolerance test
82975 Glutamine (glutamic acid amide)
For glutamine [glutamic acid amide], see 82127, 82128, 82131
82980 Glutethimide
83008 Guanosine monophosphate (GMP), cyclic
83055 Hemoglobin; sulfhemoglobin, qualitative
83071 Hemosiderin; quantitative
83634 Lactose, urine; quantitative
83805 Meprobamate
For quantitative testing for meprobamate, see 80369, 80370
83840 Methadone For methadone, use 80358
83858 Methsuximide
For methsuximide, see 80339, 80340, 80341
83866 Mucopolysaccharides, acid; screen
83887 Nicotine For nicotine, use 80323
83925 Opiate(s), drug and metabolites, each procedure
For opiates, see 80361, 80362, 80363, 80364, or the specific drug [eg, fentanyls, oxycodone]
84022 Phenothiazine For phenothiazine, see 80342, 80343, 80344
84127 Porphyrins, feces; qualitative
87001 Animal inoculation, small animal; with observation
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
87620 Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human,
direct probe technique
To report, see 87623, 87624, 87625
87621 Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human,
amplified probe technique
To report, see 87623, 87624,87625
87622 Infectious agent detection by nucleic acid (DNA or RNA); papillomavirus, human,
Quantification
To report, see 87623, 87624, 87625
88343 Immunohistochemistry or immunocytochemistry, each separately identifiable antibody per block,
cytologic preparation, or hematologic smear; each additional separately identifiable
antibody per slide (List separately in addition to code for primary procedure)
For multiplex antibody stain procedure, use 88344
88349 Electron microscopy; scanning
To report, use 88348
Revised Pathology & Laboratory CPT Codes
Strike-through – 2014 Deleted Description
Underlined – New 2015 Revixsed Description
80162 Digoxin; total
80164 DipropylaceticValproic acid (valproicdipropylacetic acid); total
80171 Gabapentin, whole blood, serum, or plasma
80299 Quantitation of therapeutic drug, not elsewhere specified
81245 FLT3 (fms-related tyrosine kinase 3) (eg, acute myeloid leukemia), gene analysis, internal tandem
duplication (ITD) variants (ie, exons 14, 15); internal tandem duplication (ITD) variants (ie, exons 14, 15)
81402 Molecular pathology procedure, Level 3 (eg, >10 SNPs, 2-10 methylated variants, or 2-10 somatic
variants [typically using non-sequencing target variant analysis], immunoglobulin and T-cell receptor
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
gene rearrangements, duplication/deletion variants of 1 exon, loss of heterozygosity [LOH], uniparental
disomy [UPD])Chromosome 1p-/19q- (eg, glial tumors), deletion analysis
81403 Molecular pathology procedure, Level 4 (eg, analysis of single exon by DNA sequence analysis,
analysis of >10 amplicons using multiplex PCR in 2 or more independent reactions, mutation scanning or
duplication/deletion variants of 2-5 exons)Human erythrocyte antigen gene analyses (eg, SLC14A1 [Kidd
blood group], BCAM [Lutheran blood group], ICAM4 [Landsteiner-Wiener blood group], SLC4A1 [Diego
blood group], AQP1 [Colton blood group], ERMAP [Scianna blood group], RHCE ]Rh blood group, CcEe
antigens], KEL [Kell blood group], DARC [Duffy blood group], GYPA, GYPB, GYPE [MNS blood group],
ART4 [Dombrock blood group]) (eg, sickle-cell disease, thalassemia, hemolytic transfusion reactions,
hemolytic disease of the fetus or newborn), common variantsRHD (Rh blood group, D antigen) (eg,
hemolytic disease of the fetus and newborn, Rh maternal/fetal compatibility), deletion analysis (eg,
exons 4, 5, and 7, pseudogene)RHD (Rh blood group, D antigen) (eg, hemolytic disease of the fetus and
newborn, Rh maternal/fetal compatibility), deletion analysis (eg, exons 4, 5, and 7, pseudogene),
performed on cell-free fetal DNA in maternal blood(For human erythrocyte gene analysis of RHD, use a
separate unit of 81403)
81404 Molecular pathology procedure, Level 5 (eg, analysis of 2-5 exons by DNA sequence analysis,
mutation scanning or duplication/deletion variants of 6-10 exons, or characterization of a dynamic
mutation disorder/triplet repeat by Southern blot analysis) MPV17 (MpV17 mitochondrial inner
membrane protein) (eg, mitochondrial DNA depletion syndrome), duplication/deletion analysisPIK3CA
(phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha) (eg, colorectal cancer) targeted
sequence analysis (eg, exon 9 and 20)
81405 Molecular pathology procedure, Level 6 (eg, analysis of 6-10 exons by DNA sequence analysis,
mutation scanning or duplication/deletion variants of 11-25 exons, regionally targeted cytogenomic
array analysis)Cytogenomic constitutional targeted microarray analysis of the X chromosome by
interrogation of genomic regions for copy number and single nucleotide polymorphism (SNP) variants
for chromosomal abnormalities(When performing genome-wide cytogenomic constitutional microarray
analysis, see 81228, 81229)(Do not report analyte-specific molecular pathology procedures separately
when the specific analytes are included as part of the microarray analysis of the X chromosome)(Do not
report 88271 when performing cytogenomic microarray analysis)Mitochondrial genome deletions (eg,
Kearns-Sayre syndrome [KSS], chronic progressive external ophthalmoplegia [CPEO], Pearson
syndrome), deletion analysis, and duplication analysis, if performed
82541 Column chromatography/mass spectrometry (eg, GC/MS, or HPLC/MS), non-drug analyte not
elsewhere specified; qualitative, single stationary and mobile phase
82542 Column chromatography/mass spectrometry (eg, GC/MS, or HPLC/MS), analyte not elsewhere
specified; quantitative, single stationary and mobile phase
82543 Column chromatography/mass spectrometry (eg, GC/MS, or HPLC/MS), analyte not elsewhere
specified; stable isotope dilution, single analyte, quantitative, single stationary and mobile phase
82544 Column chromatography/mass spectrometry (eg, GC/MS, or HPLC/MS), analyte not elsewhere
specified; stable isotope dilution, multiple analytes, quantitative, single stationary and mobile phase
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
84600 Volatiles (eg, acetic anhydride, carbon tetrachloride, dichloroethane, dichloromethane,
diethylether, isopropyl alcohol, methanol)
86900 Blood typing, serologic; ABO
86901 Rh (D)
86902 Blood typing; antigen testing of donor blood using reagent serum, each antigen test
86904 Blood typing; antigen screening for compatible unit using patient serum, per unit screened
86905 RBC antigens, other than ABO or Rh (D), each
86906 Rh phenotyping, complete
87501 Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, includes reverse
transcription, when performed, and amplified probe technique, each type or subtype
87502 Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or subtypes, includes multiplex reverse transcription and multiplex amplified probe technique, first 2 types or
sub-types
87503 Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or subtypes, includes multiplex reverse transcription and multiplex amplified probe technique, each additional
influenza virus type or sub-type beyond 2 (List separately in addition to code for primary procedure)
87631 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,
influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus,
rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe
technique, multiple types or subtypes, 3-5 targets
87632 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,
influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus,
rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe
technique, multiple types or subtypes, 6-11 targets
87633 Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus,
influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus,
rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe
technique, multiple types or subtypes, 12-25 targets
88342 Immunohistochemistry or immunocytochemistry, each separately identifiable antibody per block,
cytologic preparation, or hematologic smearspecimen; first separately identifiableinitial single antibody
per slidestain procedure
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611
88360 Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen
receptor/progesterone receptor), quantitative or semiquantitative, per specimen, each single antibody
stain procedure; manual
88361 Morphometric analysis, tumor immunohistochemistry (eg, Her-2/neu, estrogen
receptor/progesterone receptor), quantitative or semiquantitative, each antibody; using computerassisted technology
88365 In situ hybridization (eg, FISH), each probeper specimen; initial single probe stain procedure
88367 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative) each probe, using
computer-assisted technology, per specimen; using computer-assisted technologyinitial single probe
stain procedure
88368 Morphometric analysis, in situ hybridization (quantitative or semi-quantitative) each probe,
manual, per specimen; manualinitial single probe stain procedure
AdvantEdge Healthcare Solutions
ahsrcm.com 877 501 1611